Table 2.
Factor | All SLE | Active SLE | Inactive SLE | Control group | Statistically significant comparison | |
n = 41 | n = 19 | n = 22 | n = 20 | |||
(a) | (b) | (c) | (d) | |||
| ||||||
---|---|---|---|---|---|---|
VEGF ± s | 285 ± 233 | 253 ± 234 | 312 ± 404 | 208 ± 163 | — | |
MMP-9 total ± s | 262 ± 242 | 183 ± 164 | 333 ± 280 | 325 ± 168 | (a)–(b) | P = .023 |
(b)–(c)–(d) | P = .014 | |||||
(b)–(c) | P = .048 | |||||
(b)–(d) | P < .001 | |||||
| ||||||
MMP-9 active ± s | 121 ± 123 | 90 ± 71 | 147 ± 151 | 169 ± 104 | (a)–(d) | P = .035 |
(b)–(c)–(d) | P = .033 | |||||
(b)–(d) | P = .016 | |||||
| ||||||
TIMP-1 x ± s | 181 ± 67 | 193 ± 72 | 170 ± 61 | 233 ± 64 | (a)–(d) | P = .004 |
(b)–(c)–(d) | P = .038 | |||||
(c)–(d) | P = .002 |